Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3019% above fair value
$19.05−0.50 (-2.56%)
Close on Nov 20, 2026Market cap $964.87MP/E –Yield –
Cryoport gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cryoport's gross profit for the twelve months ending Jun 30, 2026 was $87.77M, up 14.1% year over year. For fiscal 2025 it was $83.05M, up 19.2% from the year before. Over ten years it grew 69.0% a year on average. The highest annual figure on record is $103.87M in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.05M | +19.2% |
| FY2024 | Dec 31, 2024 | $69.66M | -7.5% |
| FY2023 | Dec 31, 2023 | $75.33M | -27.5% |
| FY2022 | Dec 31, 2022 | $103.87M | +7.6% |
| FY2021 | Dec 31, 2021 | $96.58M | +165.8% |
| FY2020 | Dec 31, 2020 | $36.33M | +109.4% |
| FY2019 | Dec 31, 2019 | $17.35M | +69.4% |
| FY2018 | Dec 31, 2018 | $10.24M | +441.7% |
| FY2016 | Mar 31, 2016 | $1.89M | +61.7% |
| FY2015 | Mar 31, 2015 | $1.17M | +167.5% |
| FY2014 | Mar 31, 2014 | $436.96K | – |
| FY2013 | Mar 31, 2013 | -$487.28K | – |
| FY2012 | Mar 31, 2012 | -$836.82K | – |
| FY2011 | Mar 31, 2011 | -$827.48K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $22.82M | +6.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $21.91M | +17.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $21.71M | +11.4% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $21.33M | +22.3% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $21.38M | +21.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $18.64M | +23.7% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $19.49M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $17.44M | -28.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $17.66M | -28.6% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $15.07M | -44.4% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$738.00K | -102.8% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $24.27M | -8.1% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $24.73M | -14.2% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $27.07M | +21.2% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $26.28M | +13.7% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $26.42M | +12.4% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $28.84M | +13.5% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $22.34M | -9.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $23.11M | +16.2% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $23.51M | +288.3% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $25.40M | +395.5% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $24.55M | +366.9% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $19.89M | +303.4% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $6.06M | +30.9% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $5.13M | +18.2% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $5.26M | +52.2% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $4.93M | +75.1% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $4.63M | +69.1% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $4.34M | +73.2% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $3.45M | +58.2% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $2.82M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $2.74M | +612.5% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $2.50M | +474.3% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $2.18M | +347.5% |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $0 | -100.0% |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $384.00K | +63.4% |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $436.00K | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | $488.00K | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | $582.00K | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | $235.00K | – |
See a number that looks wrong?